Landong, Reynaldo Jr. L.
HRN: 29-14-40 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/13/2026
CEFTRIAXONE 1G (VIAL)
06/13/2026
06/19/2026
IV
2gm
Q24h
Cap Mr
Checking Initial Appropriateness
06/13/2026
AZITHROMYCIN 500MG TABLET (TAB)
06/13/2026
06/17/2026
PO
500mgtab
Q24
Cap Mr
Checking Initial Appropriateness
06/19/2026
TENOFOVIR DISOPROXIL FUMARATE 300MG TAB
06/19/2026
07/31/2026
PO
300
OD
HIV
Checking Initial Appropriateness
06/19/2026
BENZATHINE BENZYLPENICILLIN 1.2M UNITS VIAL
06/19/2026
07/24/2026
IM
2.4
Once A Week
HIV
Checking Initial Appropriateness
06/19/2026
COTRIMOXAZOLE 960MG (TAB)
06/19/2026
06/26/2026
ORAL
2 Tabs
TID
Pneumonia In Immunocompromised
Checking Initial Appropriateness
06/21/2026
COTRIMOXAZOLE 960MG (TAB)
06/21/2026
07/11/2026
PO
160/800mg
TID
Pneumonia In Immunocompromised Host
Checking Initial Appropriateness
06/21/2026
CEFTAZIDIME 1GM (VIAL)
06/21/2026
06/28/2026
IV
2g
Q8
PCP
Checking Initial Appropriateness
06/26/2026
BENZATHINE BENZYLPENICILLIN 1.2M UNITS VIAL
06/26/2026
06/26/2026
IM
2.4mu
Once A Wk
HIV
Checking Initial Appropriateness